Schedule 13G ownership disclosure

Ultragenyx Pharmaceutical Inc

COMMON STOCK · CUSIP: 90400D108

Event date: 2026-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • STATE STREET CORPORATION

    Shares: 7,538,078.00 · Class: 7.6%

  • SSGA FUNDS MANAGEMENT, INC.

    Shares: 5,318,630.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000093751-26-000734
Form type
SCHEDULE 13G
Filer
Ultragenyx Pharmaceutical Inc.
CIK
CIK 1515673
Filed
Nov 10, 2026
Reporting period
Sep 30, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub